radial artery occlusion
Conditions
Interventions
Standard patency hemostasis:“SUPER” Patent Hemostasis Method
Standard patency hemostasis:Standard patency hemostasis
Sponsors
Nanjing Lishui Peolpe's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 79 Years
Inclusion criteria
Inclusion criteria: 1.Age = 18 years and < 80 years; 2.Patients undergoing coronary angiography in the cardiology department; 3.Patients with clear consciousness, understanding and expression ability; 4.Patients who are willing to participate in the study and provide written informed consent; 5.Antiplatelet drug use: aspirin enteric-coated tablet 300mg+ ticagrelor tablet 180mg/ Clopidogrel bisulfate tablet 300mg one day before surgery; On the day of surgery, aspirin enteric-coated tablet 100mg+ ticagrelor tablet 90mg/ Clopidogrel bisulfate tablet 75mg;
Exclusion criteria
Exclusion criteria: 1.Patients with upper limb disability or deformity; 2.Patients with local skin or tissue edema or infection; 3.Patients with coagulation dysfunction or severe comorbidities who have had two or more ipsilateral radial artery punctures; 4.The puncture point is not 1-2cm below the metacarpal stripe;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of 24-hour RAO; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of vascular complications;Bleeding complication rate;convenience; | — |
Countries
China
Contacts
Public ContactDunfu Zhang
Nanjing Lishui Peolpe's Hospital
Outcome results
None listed